Ampio Pharmaceuticals, Inc.
AMPE · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $114 | $275 |
| - Cash | $4 | $13 | $34 | $17 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | -$2 | -$9 | $81 | $259 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$2 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$23 | -$16 | -$15 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$16 | -$17 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -10.66 | -29.32 | -18.59 | -27.59 |
| % Growth | 63.6% | -57.7% | 32.6% | – |
| Operating Cash Flow | -$9 | -$21 | -$14 | -$15 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$9 | -$21 | -$14 | -$15 |